フジックス株式会社

About us

会社概要

Company Outline Fujix Corporation

Company Name Fujix Corporation
Head Office 5-59-5 Yoyogi, Shibuya-ku, Tokyo 151-0053, Japan TEL +81-3-3460-0712 FAX +81-3-3460-0812
Established May 18th, 1972
Board Director Takeshi Inoue,Ph.D.
Capital 10,000,000 JPY

Corporate History

1972 Fuji Kikaku Co., Ltd. established. Started off with the planning and development as well as the manufacture of educational materials and toys for infants. Launched many hit products.
1986 Obtained a patent for the formula for ionized calcium using oyster shells as raw ingredients.
1987 Commenced sale of Active Absorbable Calcium under the product name 'FUJICAL' at All Japan Drug Chain outlets.
Participated in the newly inaugurated joint public-private sector project 'Basic Scientific Research Projects in Honor of Longevity' . In collaboration with the National Institution of Nutrition, the Faculty of Medicine of Kobe University, and the Faculty of Pharmaceutical Sciences of Tokyo University of Science, conducted joint research on Active Absorbable Calcium over a period of 3 years, for which a research fund of 30 million yen was granted by the Government.
1988 Active Absorbable Calcium sold at drugstores and pharmacies nationwide via Ohki Co., Ltd. under the product name 'AA Calcium', a best-selling calcium product in the market.
1990 Changed corporate name from Fuji Kikaku Co., Ltd. to FUJIX Corporation.
1991 Set up a laboratory in Ibaraki City, Osaka, and embarked on the research and development of Active Absorbable Algal Calcium(AAA Calcium,3ACalcium).
1995 Entered into a business partnership with Dainippon Ink and Chemicals, Incorporated for the sales operations of '3A Calcium' (until October 1997).
1997 At the Second International Symposium on Osteoporosis (held at Hotel New Otani Osaka), in the lecture entitled "The Past, Present & Future of Osteoporosis" by Honorary Chairman Dr. Takuo Fujita and in the Symposium on Calcium Supplementation, data on our '3A Calcium' were presented, and the high absorbability of this product won the attention of researchers attending from various countries.
1998 Launched '3A Magnesia' as a medical product. Manufactured by using active magnesium with a higher water-trapping ability than the conventional magnesium listed in the Japanese Pharmacopoeia, this laxative which does not result in stomach aches and is free of side effects, became a huge hit.
2000 Developed an epoch-making product by adding collagen and composite mucopolysaccharide to calcium, and started to market this new product.
2001 Obtained US patent for calcium antagonist.
Takeshi Inoue assumed the post of Representative Director.
2002 Obtained US patent for laxative containing active magnesium.
2003 Signed a business partnership with Lane Labs-USA, Inc. for sales operations. 3A Calcium and 3A Magnesia began to be shipped to North America, via Lane Labs-USA.
2004 Commenced full-scale shipment to USV Ltd., India. 3A Calcium approved as a medical product in India.
2006 Signed a business partnership with USV Ltd., India for sales operations(World wide exclude US and Japan).
2009 Title ; Fractional Absorption of Active Absorbable Algal Calcium (AAACa) and Calcium Carbonate Measured by Dual Stable Isotope Method

Product

製品情報

フジックス株式会社は、「おなかが痛くなりにくい・活性酸化マグネシウム便秘薬」と
「吸収率が優れた3Aカルシウム」のパイオニアです。

製品情報一覧

Contact us

お問い合わせ

製品・サービスに関するご相談、カタログ請求、お探しの情報が見つからない場合など、
ご不明な点がある場合はお気軽にお問い合わせください。

お電話でのお問い合わせ

03-3460-0762
営業時間 9:00~17:30 休業日 土・日・祝日

メールフォームでのお問い合わせ

お問い合わせ
お問い合わせフォームよりご連絡ください。